Search results
Author(s):
Michael F Morris
,
Philip A Araoz
Added:
3 years ago
Mitral valve dysfunction is the most common cause of valvular disease in the US.1 Although echocardiography is the primary non-invasive modality for visualizing the mitral valve, advances in technology continue to allow for improved evaluation of mitral disease with magnetic resonance imaging (MRI) and computed tomography (CT).2,3 Currently, the role for MRI and CT assessment of the mitral valve…
View more
Author(s):
Jean-Bernard Masson
,
Jessica Forcillo
Added:
2 years ago
Author(s):
Mehmet Ali Elbey
,
Luis Augusto Palma Dallan
,
Guilherme Ferragut Attizzani
Added:
3 years ago
The field of mitral valve disease diagnosis and management is in constant change. New understanding of disease pathology and progression, with improvements in and increased use of sophisticated imaging modalities have led to more complex treatments. Transcatheter mitral valve repair with a MitraClip device is resulting in good outcomes in patients with primary mitral regurgitation who are at high…
View more
BAV: SAVR versus TAVR
Author(s):
Arthur J Lee
,
Imran Baig
,
Katherine B Harrington
,
et al
Added:
1 year ago
Article
Author(s):
James Gammie
Added:
2 years ago
In this short interview, Dr James Gammie (University of Maryland Medical Center, MD, US) discusses the findings from surgical trial assessing the benefit of concomitant tricuspid repair during mitral valve surgery. The trial, presented at AHA 2021, demonstrated that at 2 years, TA had no impact on MACCE, survival, or QOL.
Discussion Points
1. Reasoning for this Study
2. Study Design and…
View more
Author(s):
Denton A Cooley
Added:
3 years ago
Innovative technologies and refinements of existing therapies are shaping 21st century cardiovascular diagnosis and treatment. Researchers are gaining new perspectives on diseases and their treatment at the cellular and subcellular levels. Cardiologists are evaluating and treating coronary arteries by means of intravascular intervention. Surgeons are shortening recovery times and increasing cost…
View more
Author(s):
Nehal Dhaduk
,
Adib Chaus
,
David Williams
,
et al
Added:
2 weeks ago
Author(s):
Alexandra Gonçalves
,
Carla Sousa
,
José Alberto de Agustín
,
et al
Added:
3 years ago
Valvular disease is the most prevalent structural heart disease among adults and its burden is growing along with the increase in life expectancy.1 Mitral regurgitation (MR) is the second most frequent valvular disease, after aortic stenosis. Its natural history is very variable and highly dependent on the presence of symptoms. However, even in asymptomatic patients, the prognosis of severe MR is…
View more
Author(s):
Jacob Green
,
Vasilis Babaliaros
,
Peter Block
Added:
3 years ago
Mitral regurgitation (MR) is the most prevalent form of valvular heart disease. Its major causes are primary mitral leaflet abnormalities (valve prolapse, healed endocarditis, or rheumatic disease), primary myocardial disease (functional MR), and ischemic disease. Even with severe MR, affected individuals may remain asymptomatic for long periods of time.1 The early, compensated state of MR is…
View more
Author(s):
Howard C Herrmann
Added:
3 years ago
Mitral regurgitation (MR) is most often caused by degenerative disease of the leaflets or develops functionally as a consequence of left ventricular disease (see Figure 1). Patients with severe MR have dyspnea on exertion, fatigue, and, when associated with left ventricular dysfunction or pulmonary hypertension, reduced survival.1 Therefore, surgery to repair or replace the mitral valve is…
View more